Seelos Therapeutics, Inc. (SEEL) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1160417,
    "name": "Seelos Therapeutics, Inc.",
    "stock_name": "Seelos Therapeutics, Inc.",
    "full_name": "Seelos Therapeutics, Inc.",
    "name_url": "stocks-analysis/seelos-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "0.00",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "0.00",
    "mcapval": "",
    "mcap": "",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US81577F2083",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "410 ",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/seelos-therapeutics-inc-1160417-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Seelos Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-seelos-therapeutics-inc-technically-bullish-or-bearish-3548077",
        "imagepath": "",
        "date": "2025-09-20 20:09:12",
        "description": "As of 24 February 2025, the technical trend for Seelos Therapeutics, Inc. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD is also mildly bullish. However, the monthly RSI is bearish, and the daily moving averages are mildly bearish. The Bollinger Bands show a sideways trend on the weekly timeframe and a mildly bearish trend on the monthly timeframe. The KST is mildly bullish weekly but bearish monthly, and Dow Theory shows no trend in both weekly and monthly perspectives. \n\nOverall, the technical stance is mildly bearish, with mixed signals across different indicators. Notably, the company has experienced a -100% return year-to-date and over the past year, significantly underperforming the S&P 500, which has returned 12.22% and 17.14% respectively...."
      },
      {
        "title": "Is Seelos Therapeutics, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-seelos-therapeutics-inc-overvalued-or-undervalued-3544244",
        "imagepath": "",
        "date": "2025-09-20 18:41:30",
        "description": "As of 15 April 2025, the valuation grade for Seelos Therapeutics, Inc. has moved from risky to does not qualify, indicating a significant deterioration in its investment appeal. The company appears to be overvalued given its current metrics, particularly with a P/E ratio of 0.00 and an EV to EBITDA of -0.33, which suggests a lack of profitability and negative enterprise value relative to earnings. Additionally, the ROE stands at an exceptionally high 106.13%, but this is misleading due to the negative capital employed, further complicating the valuation picture.\n\nIn comparison to its peers, Seelos Therapeutics is underperforming, with Pieris Pharmaceuticals showing a P/E of -25.1964 and Coeptis Therapeutics at -4.6862, indicating that these companies are also struggling but at different levels. The stock has experienced a dramatic decline, with a year-to-date return of -100%, contrasting sharply with the S&..."
      }
    ],
    "total": 6,
    "sid": "1160417",
    "stock_news_url": "https://www.marketsmojo.com/news/seelos-therapeutics-inc-1160417"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Seelos Therapeutics, Inc. technically bullish or bearish?

2025-09-20 20:09:12

As of 24 February 2025, the technical trend for Seelos Therapeutics, Inc. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD is also mildly bullish. However, the monthly RSI is bearish, and the daily moving averages are mildly bearish. The Bollinger Bands show a sideways trend on the weekly timeframe and a mildly bearish trend on the monthly timeframe. The KST is mildly bullish weekly but bearish monthly, and Dow Theory shows no trend in both weekly and monthly perspectives. Overall, the technical stance is mildly bearish, with mixed signals across different indicators. Notably, the company has experienced a -100% return year-to-date and over the past year, significantly underperforming the S&P 500, which has returned 12.22% and 17.14% respectively....

Is Seelos Therapeutics, Inc. overvalued or undervalued?

2025-09-20 18:41:30

As of 15 April 2025, the valuation grade for Seelos Therapeutics, Inc. has moved from risky to does not qualify, indicating a significant deterioration in its investment appeal. The company appears to be overvalued given its current metrics, particularly with a P/E ratio of 0.00 and an EV to EBITDA of -0.33, which suggests a lack of profitability and negative enterprise value relative to earnings. Additionally, the ROE stands at an exceptionally high 106.13%, but this is misleading due to the negative capital employed, further complicating the valuation picture. In comparison to its peers, Seelos Therapeutics is underperforming, with Pieris Pharmaceuticals showing a P/E of -25.1964 and Coeptis Therapeutics at -4.6862, indicating that these companies are also struggling but at different levels. The stock has experienced a dramatic decline, with a year-to-date return of -100%, contrasting sharply with the S&...

View All News